An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes
AbstractBioinformatics is the use of computers for the storage, recall and analysis of data derived from scientific research aimed at providing answers to biological questions. Increasingly pharmaceutical firms are choosing to incorporate bioinformatics into their drug research and development (R&D) programs. Based on examination of recent literature and case studies of a cross section of the pharmaceutical industry and research community, this research concludes the following key points: Bioinformatics has been widely accepted as a new core competency for pharmaceutical research. Pharmaceutical firms are broadening their competencies to different extents to access new technologies. Integrated bioinformatics systems are systemic innovations and require strong in-house capabilities, however bioinformatics tools may also be used in an autonomous manner. Thus two groups of industrial users are emerging: those who use bioinformatics tools piecemeal and those who are attempting to integrate these tools into systems. Integration poses a complex set of technical and organisational problems, but may enable high throughput programs for drug discovery that optimise resources more effectively and thus provide competitive advantages. Such integrated systems must be tailor-made and are possible only through gaining competencies that are difficult to replicate. Additionally in this study theoretical frameworks are used to map technological change in the pharmaceutical process, showing how barriers to innovation and limiting steps within the R&D process are changing as a result of bioinformatics.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by SPRU - Science and Technology Policy Research, University of Sussex in its series SPRU Working Paper Series with number 32.
Length: 76 pages
Date of creation: 01 Jun 1999
Date of revision:
Contact details of provider:
Postal: Jubilee Building G08, Falmer, Brighton, BN1 9SL
Phone: +44 (0)1273 686758
Fax: +44 (0)1273 685865
Web page: http://www.sussex.ac.uk/spru
More information through EDIRC
bioinformatics; pharmaceutical industry; R&D; research and development; innovation;
Find related papers by JEL classification:
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
- O3 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Russell Eke).
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.